CNS tumors (e.g. neuroblastoma) frequently express NRP-2 [29], and NRP-2 expression is also elevated in high-grade prostate cancers with PTEN loss [30], a frequent event in glioblastoma [31]. This evidence concerns the gene PTEN and prostate carcinoma.